Home/Filings/4/0001127602-21-017273
4//SEC Filing

Goldstein Dan 4

Accession 0001127602-21-017273

CIK 0000313143other

Filed

May 17, 8:00 PM ET

Accepted

May 18, 6:31 PM ET

Size

5.0 KB

Accession

0001127602-21-017273

Insider Transaction Report

Form 4
Period: 2021-05-17
Goldstein Dan
Chief Accounting Officer
Transactions
  • Sale

    Common Stock

    2021-05-17$55.97/sh42$2,3511,469 total
Footnotes (2)
  • [F1]Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain restricted stock units ("RSUs") previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2005 Long Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
  • [F2]This number includes unvested RSUs previously reported.

Issuer

HAEMONETICS CORP

CIK 0000313143

Entity typeother

Related Parties

1
  • filerCIK 0001722327

Filing Metadata

Form type
4
Filed
May 17, 8:00 PM ET
Accepted
May 18, 6:31 PM ET
Size
5.0 KB